vimarsana.com

Page 29 - அறிக்கை தொடர்பாக முன்னோக்கி பார்க்கிறது News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vir Biotechnology and GSK Announce VIR-7831 Reduces Hospitalization and Risk of Death in Early Treatment of Adults with COVID-19

Vir Biotechnology and GSK Announce VIR-7831 Reduces Hospitalization and Risk of Death in Early Treatment of Adults with COVID-19 March 10, 2021 20:22 ET | Source: Vir Biotechnology, Inc. Vir Biotechnology, Inc. San Francisco, California, UNITED STATES – Independent Data Monitoring Committee recommends stopping Phase 3 COMET-ICE trial early given an 85% reduction in hospitalization or death – – Vir and GSK plan to immediately seek Emergency Use Authorization in the U.S. and authorizations in other countries – – Additional new in vitro studies indicate VIR-7831 maintains activity against major circulating COVID-19 variants – SAN FRANCISCO and LONDON, March 10, 2021 (GLOBE NEWSWIRE) Vir Biotechnology, Inc. (Nasdaq: VIR) and GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that an Independent Data Monitoring Committee (IDMC) recommended that the Phase 3 COMET-ICE (COVID-19 Monoclonal antibody Efficacy Trial - Int

Vir Biotechnology and GSK Announce VIR-7831 Reduces Hospitalization and Risk of Death in Early Treatment of Adults with COVID-19

Vir Biotechnology and GSK Announce VIR-7831 Reduces Hospitalization and Risk of Death in Early Treatment of Adults with COVID-19
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Canada House Wellness Group Announces Grant of Stock Options

TORONTO, March 9, 2021 /CNW/ - Canada House Wellness Group (CSE: CHV) ( Canada House or the Company ), announced today that its board of directors has approved the grant of an aggregate of 21,925,000 incentive stock options (the Options ) to certain officers, employees (excluding the Company s executive management team), and consultants of the Company and its subsidiaries. The Options are exercisable at a price of $0.05 per share and will vest consistent with Company policy and past practices.  Additionally, all of the Options have a five-year term and are based on Canada House s stock option plan and the requirements of the Canadian Securities Exchange. About Canada House Wellness Group

Kenorland Commences Drilling at Regnault on the Frotet Project in Quebec

Kenorland Commences Drilling at Regnault on the Frotet Project in Quebec News provided by Share this article Kenorland Minerals Ltd. (TSXV: KLD) ( Kenorland or the Company ) is pleased to announce the commencement of drilling at Regnault within the Frotet Project (the Project ) located in the Frotet-Evans greenstone belt of Quebec.  The program will include up to 9,000 meters of diamond drilling to follow-up on the initial discovery made in 2020 where the Company intersected 29.08m at 8.47g/t Au including 11.13m at 18.43g/t Au during the maiden drill program testing a greenfield target (see press release dated July 29, 2020). Figure 1. Map of the Regnault Area (CNW Group/Kenorland Minerals Ltd.)

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.